BlueTree Allied Angels is a members-only group of accredited investors focused on funding promising start-up companies. It is self-described as Western Pennsylvania's leading angel network.

BlueTree Allied Angels

We invest time and capital in strong early-stage companies to help them succeed.

Wombat Security Technologies

DiaKine Therapeutics

TalkShoe

Voci Technologies

NewCare Solutions

C360 Technologies

ALung Technologies

Cognition Therapeutics

See what Lindsay Watson PT, MPT, Co-founder and CEO of Augment Therapy, says about the #northeastohioregion! Learn more about her thoughts on the assets and strengths of Northeast Ohio as an entrepreneur in the region by clicking here➡️https://bit.ly/3EM4FQg

#NEOhio #TeamNEO #EconDev #economicvibrancy #vibranteconomy #VEI

CytoAgents is at the forefront of biotech innovation, developing an effective solution for Cytokine Release Syndrome (CRS), otherwise known as Cytokine Storm.

Our CEO, Teresa Whalen, RPh, is leading the charge to bring our life-changing drug to market. She is an experienced biotech leader who has a successful track record as a healthcare executive and investor. She has also been called on to report on innovation and emerging technology for state policymakers.

Learn more about Teresa and the CytoAgents leadership team here: https://lnkd.in/g7P29x3i

#biotechnology #biotech #healthcareleaders #cycokinereleasesyndrome

Chimeric antigen receptor (CAR) T-cell therapy is changing the landscape for treatment options for patients with certain types of cancer. Researchers continue to look for ways to expand this therapy to impact a greater number of patients.

One major risk to this form of treatment is a life-threatening side effect known as Cytokine Release Syndrome (CRS), which is an overreaction of the immune system. Learn how CytoAgents' solution will address this side effect and make CAR T-cell therapy safer for patients: https://cytoagents.com/

#cytokinereleasesyndrome #crs #cytokines #cartcelltherapy Teresa Whalen, RPh

Looking forward to seeing where this partnership takes both companies.  A great solution for a population that needs ways to more efficiently do their job.

msh id	COM:BLUETREEALLIEDANGELS
symbol	-
name	BlueTree Allied Angels
homepage url	https://www.bluetreealliedangels.com
country	US
sector	Financial Services & Finance
industry	Angel Investing
market	PRIVATE
employee count	14
crunchbase url	-
linkedin url	https://www.linkedin.com/company/bluetree-allied-angels
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

BLUE

COM:BLUETREEALLIEDANGELS

BlueTree Allied Angels

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-